What is the official ID of this bill?

The official print number for this legislation is HR 4134.

When did the legislative process begin?

The process officially started on 2023-06-14.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/hr4134/BILLS-118hr4134ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Who is the primary sponsor?

The primary sponsor is Rep. Schiff, Adam B. [D-CA-30].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Analysis and Potential Impact of HR 4134

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Drug Labeling Update: Enhanced Patient Safety

Q: What are the main provisions?

Key points include: Generic drug manufacturers will be able to update labels faster to include new safety information. These changes can be made even before official approval by relevant authorities, speeding up access to important warnings. All generic drugs linked to a specific reference drug will be required to have consistent and up-to-date labels.

New regulations aim to ensure that safety information for generic drugs is quickly updated. This will provide citizens with access to the latest data on potential risks, increasing their safety when taking medications.

Key points

Generic drug manufacturers will be able to update labels faster to include new safety information.

These changes can be made even before official approval by relevant authorities, speeding up access to important warnings.

All generic drugs linked to a specific reference drug will be required to have consistent and up-to-date labels.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Updated Drug Labeling for Patient Safety Act

Print number: HR 4134

Sponsor: Rep. Schiff, Adam B. [D-CA-30]

Process start date: 2023-06-14

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Drug Labeling Update: Enhanced Patient Safety

Key Questions about Drug Labeling Update: Enhanced Patient Safety